News

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...
Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
Alzheimer’s experts welcomed the study but noted weight loss jabs combat diabetes and obesity, both of which can contribute to the development of dementia | ITV National News ...
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...